Dermatitis, Atopic: all 1,443 studies

Page 5 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyCompletedNCT03720470Phase 3Results posted
• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT03706040Phase 2Results posted
• Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic DermatitisCompletedNCT03703102Phase 2Results posted
• The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT03667014Phase 4Results posted
• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03654755Phase 2Results posted
• ASPIRE: PROs & Caregiver Burden in Children With Atopic DermatitisCompletedNCT03645057Phase 3Results posted
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring SubjectsCompletedNCT03627767Phase 3Results posted
• A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)CompletedNCT03607422Phase 3Results posted
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTENDCompletedNCT03587805Phase 3Results posted
• A Study of ATI-502 Topical Solution for the Treatment of Atopic DermatitisCompletedNCT03585296Phase 2Results posted
• Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03575871Phase 3Results posted
• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)CompletedNCT03569293Phase 3Results posted
• Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)CompletedNCT03568331Phase 3Results posted
• A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT03568318Phase 3Results posted
• Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic DermatitisCompletedNCT03568162Phase 2Results posted
• Effect of Benralizumab in Atopic DermatitisCompletedNCT03563066Phase 2Results posted
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)CompletedNCT03562377Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic DermatitisTerminatedNCT03559270Phase 3Results posted
• A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate ADTerminatedNCT03539601Phase 4Results posted
• Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT03533751Phase 2Results posted
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)CompletedNCT03531957Phase 2Results posted
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).CompletedNCT03526861Phase 3Results posted
• A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic DermatitisTerminatedNCT03517566Phase 2Results posted
• A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03496974Phase 2Results posted
• A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic DermatitisCompletedNCT03492398Phase 1Results posted
• A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT03443024Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03435081Phase 3Results posted
• A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically AdvisableCompletedNCT03428100Phase 3Results posted
• A Community-based Assessment of Skin Care, Allergies, and EczemaCompletedNCT03409367Not applicableResults posted
• Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic DermatitisTerminatedNCT03389893Phase 4Results posted
• 8-Week Atopic Dermatitis (AD) Treatment StudyCompletedNCT03386032Phase 3Results posted
• Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3CompletedNCT03363854Phase 3Results posted
• Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)CompletedNCT03359356Phase 2Results posted
• A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic DermatitisCompletedNCT03356977Phase 4Results posted
• Study to Evaluate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic DermatitisCompletedNCT03349060Phase 3Results posted
• Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to <6 Years With Moderate-to-Severe Atopic Dermatitis (Liberty AD PRESCHOOL)CompletedNCT03346434Phase 2/3Results posted
• Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)CompletedNCT03345914Phase 3Results posted
• A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic DermatitisCompletedNCT03334435Phase 3Results posted
• Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334422Phase 3Results posted
• A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03334396Phase 3Results posted
• Immunogenetic Profiling of Dupilumab for the Treatment of Atopic DermatitisCompletedNCT03293030Phase 4Results posted
• A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic DermatitisCompletedNCT03260595Phase 1Results posted
• Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic DermatitisCompletedNCT03250624Phase 2Results posted
• Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic DermatitisCompletedNCT03235024Phase 2Results posted
• Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic DermatitisCompletedNCT03233529Phase 2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)CompletedNCT03160885Phase 3Results posted
• Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis PatientsCompletedNCT03158012Phase 1Results posted
• Targeted Microbiome Transplant in Atopic DermatitisCompletedNCT03151148Phase 1/2Results posted
• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)CompletedNCT03131648Phase 3Results posted
• Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic DermatitisCompletedNCT03107611Phase 3Results posted
• Dose-ranging Study of Nemolizumab in Atopic DermatitisCompletedNCT03100344Phase 2Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult SubjectsCompletedNCT03058783Phase 3Results posted
• Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03055195Phase 2Results posted
• Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic DermatitisCompletedNCT03054428Phase 3Results posted
• Evaluating Treatment Resistant Dermatitis TaroIIRCompletedNCT03050294Phase 4Results posted
• Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03018691Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic DermatitisCompletedNCT03011892Phase 2Results posted
• Insulin Sensitivity in Patients With Atopic DermatitisCompletedNCT03003793Results posted
• Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)CompletedNCT03002571Phase 3Results posted
• Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic DermatitisCompletedNCT02975206Phase 2Results posted
• Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic DermatitisCompletedNCT02945657Phase 2Results posted
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.CompletedNCT02932891Phase 2Results posted
• Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)CompletedNCT02925793Phase 2Results posted
• A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic DermatitisCompletedNCT02925117Phase 2Results posted
• Study of OPA-15406 Ointment in Patients With Atopic DermatitisCompletedNCT02914548Phase 2Results posted
• Topical NanoDox® for Atopic DermatitisCompletedNCT02910011Phase 2Results posted
• A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic DermatitisCompletedNCT02871479Phase 2Results posted
• Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT02864498Phase 2Results posted
• A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic DermatitisCompletedNCT02795832Phase 1/2Results posted
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic DermatitisCompletedNCT02791308Phase 3Results posted
• Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic DermatitisCompletedNCT02780167Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableCompletedNCT02755649Phase 3Results posted
• Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic DermatitisCompletedNCT02743871Phase 1Results posted
• Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With EczemaCompletedNCT02691507Phase 2Results posted
• To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic DermatitisCompletedNCT02683928Phase 2Results posted
• Topical Steroid Formulation and Wet WrapsCompletedNCT02680301Phase 4Results posted
• An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic DermatitisCompletedNCT02655679Phase 1/2Results posted
• Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisCompletedNCT02651714Phase 2Results posted
• Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisCompletedNCT02595073Phase 3Results posted
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic DermatitisCompletedNCT02595008Phase 2Results posted
• Secukinumab for Treatment of Atopic DermatitisCompletedNCT02594098Phase 2Results posted
• Cetaphil Restoraderm Effect on Young Children With Atopic DermatitisCompletedNCT02589392Not applicableResults posted
• A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02576938Phase 2Results posted
• A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)CompletedNCT02564055Phase 2Results posted
• Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic DermatitisCompletedNCT02525094Phase 2Results posted
• A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic DermatitisCompletedNCT02424253Phase 2Results posted
• A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)CompletedNCT02407756Phase 2Results posted
• A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)CompletedNCT02395133Phase 3Results posted
• Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczemaCompletedNCT02357940Not applicableResults posted
• Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic DermatitisCompletedNCT02347176Phase 2Results posted
• Pilot Efficacy and Safety Study of AQX-1125 in Atopic DermatitisCompletedNCT02324972Phase 2Results posted
• A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS WithdrawalTerminatedNCT02317276Phase 4Results posted
• Oregano Ointment vs. Standard Treatment for Pediatric Atopic DermatitisTerminatedNCT02289989Not applicableResults posted
• Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277769Phase 3Results posted
• Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompletedNCT02277743Phase 3Results posted
• Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02260986Phase 3Results posted
• Oral DS107 in Moderate to Severe Atopic DermatitisCompletedNCT02211417Phase 2Results posted
• Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)CompletedNCT02210780Phase 2Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic DermatitisCompletedNCT02118792Phase 3Results posted
• Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisCompletedNCT02118766Phase 3Results posted

← Dermatitis, Atopic overview